Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;29(3):181-6.
doi: 10.3109/02813432.2011.585277. Epub 2011 Jul 11.

Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population

Erik Jedenius  1 , Kristina Johnell, Johan Fastbom, Jan Strömqvist, Bengt Winblad, Niels Andreasen
Affiliations

Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population

Erik Jedenius et al. Scand J Prim Health Care. 2011 Sep.

Abstract

Background and objective: The number of elderly persons in society is increasing, placing additional demands on the public health system. Extensive use of drugs is common in the elderly, and in patients with dementia this further increases their vulnerability. Since 1998 the municipality of Kalmar, Sweden, has worked with a dementia management programme that focuses on early intervention in order to identify the patient's help needs at an early stage. An important part of the programme aims at optimizing pharmacological treatment. The objective of the present study is to evaluate whether the dementia programme had a secondary effect on the use of psychotropic medication in the elderly population in general.

Design and setting: A retrospective, drug utilization study analysing the use of selected drug categories by the elderly (75 years and older) in the Kalmar municipality compared with the whole of Sweden.

Results and conclusions: The results suggest that the dementia programme contributed to an improvement in psychotropic drug use in the elderly as a secondary effect. Furthermore, the implementation of this programme did not require allocation of extra funding.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Yearly sales of antidementia drugs (N06D) expressed as DDD/1000 persons 75 years and older in Kalmar and Sweden from 2000 to 2005 (Kalmar n = 5510 and the whole of Sweden n = 796, 799).
Figure 2.
Figure 2.
Yearly sales of the major drugs with anticholinergic activity (G04BD, N05AA, N05AC02, N05BB01, N06AA) DDD/1000 persons 75 years and older in Kalmar and Sweden (Kalmar n = 5510 and the whole of Sweden n = 796, 799).
Figure 3.
Figure 3.
Yearly sales of neuroleptic drugs (N05A) DDD/1000 persons 75 years and older in Kalmar and Sweden (Kalmar n = 5510 and the whole of Sweden n = 796, 799). Author(s):Jedenius, Johnell, Fast-bom, Strömqvist, Winblad, Andreasen
See this image and copyright information in PMC

References

    1. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 1999;15:365–75. - PubMed
    1. WHO. WHO Collaborating Centre for Drug Statistics Methodology. 2008. [cited 2007]; available from: http://www.whocc.no/atcddd/
    1. Pehrsson Å, Lindström E, Kohl E, Jarnehammar K, Hirsch C, Lönnebo M, et al. Report No. 6504–02. Stockholm: Norra Stockholms läkemedelskommité; 2002 May 2002. Läkemedelsgenomgångar på Kungsholmen och Norrmalm. [Drug revue in Kungsholmen and Norrmalm. Report No. 6504-02. Stockholm: Northern Stockholm Pharmaceutical Committee]
    1. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. 2003;1:82–9. - PubMed
    1. Hanlon JT, Lindblad CI, Hajjar ER, McCarthy TC. Update on drug-related problems in the elderly. Am J Geriatr Pharmacother. 2003;1:38–43. - PubMed

Publication types